JaroslawPMaciejewskiMD

PubMed

• 167 citations
  Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations.
  Britta Will, Li Zhou, Thomas O. Vogler, Susanna Ben-Neriah, Carolina Schinke
  Blood. 2012-09-06
• 93 citations
  The use of immunosuppressive therapy in MDS: clinical outcomes and their predictors in a large international patient cohort
  Maximilian Stahl, Michelle DeVeaux, Theo de Witte, Judith Neukirchen, Mikkael A. Sekeres
  Blood Advances. 2018-07-24
• 22 citations
  Molecular landscape of immune pressure and escape in aplastic anemia.
  Simona Pagliuca, Carmelo Gurnari, Colin Hercus, Sébastien Hergalant, Niroshan Nadarajah
  Leukemia. 2023-01-01

Journal Articles

• Germline Loss of Function SAMD9 and SAMD9L Alterations in Adult Myelodysplastic Syndromes  
  Samuel Li, Mikkael A Sekeres, Jaroslaw P Maciejewski, Rabi Hanna, Blood
• Mutational Landscape of myelodysplastic/myeloproliferative Neoplasm – Unclassifiable (MDS/MPN-U)  
  Aziz Nazha, Rami S Komrokji, Andrew Sochacki, Mikkael A Sekeres, Prithviraj Bose, Courtney D DiNardo, Hagop M Kantarjian, Srdan Verstovsek, Sanam Loghavi, Jaroslaw P M..., Blood

Abstracts/Posters

• Feedback Responses of the Pyrimidine Metabolism Network Mediate Resistance to Decitabine and 5-Azacytidine
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Large Granular Lymphocytic Leukemia Coexists with Clonal Hematopoiesis of Indeterminate PotentialClinically Relevant Abstract
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Long-Term Experience with Large Granular Lymphocytic Leukemia Evolving after Solid Organ and Hematopoietic Stem Cell Transplantation
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Molecular Dissection of Del(5q): Distinction between Primary and Secondary Del(5q) and Pathogenetic Implications
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Angioimmunoblastic T-Cell Lymphoma: Molecular Characterization of Clonal T and B-Cells and a Patient Derived Xenograft Model of Coexisting T and B-Cell Proliferations
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Interactions between Donor Activating Killer Immunoglobulin-like Receptors (KIRs) and Somatic Mutations and Their Association with Outcomes after Allogeneic Hematopoie...
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• ANKRD26 Coding Variants Presenting with Giant Platelets and a Predisposition to Myeloid Neoplasia
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Clonal Cytopenias of Undetermined Significance Are Common in Cytopenic Adults Evaluated for MDS in the National MDS Study
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Eltrombopag Creates a Transient Chemical Phenocopy of TET2 Loss of Function That Contributes to Hematopoietic Precursor ExpansionClinically Relevant Abstract
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• TET Dioxygenase Inhibition As a Therapeutic Strategy in TET2 Mutant Myeloid Neoplasia
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Genetics of Monosomy 7 and Del(7q) in MDS Informs Potential Therapeutic Targets
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Pattern of Somatic Mutation Changes from Diagnosis to Relapse Following Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Acute Myeloid Leukemia (AML) and My...
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Geno-Clinical Model for the Diagnosis of Bone Marrow Myeloid Neoplasms
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Reversible TET Inhibitor As a Hematopoietic Stem Cell Booster: A Novel Strategy to Improve Stem Cell Function
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Pharmacologic Normalization of Altered Transcriptome of SF3B1 Mutant Myeloid Neoplasia
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Extended Experience with a Very Low Dose, Metronomic, Subcutaneous Decitabine Regimen Intended to Deplete DNMT1 without Cytotoxicity
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Molecular Characterization of Leukemia Evolving from Paroxysmal Nocturnal Hemoglobinuri
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Effects of the Therapeutic Armamentarium on Survival and Time to Next Treatment in CMML Subtypes: An International Analysis of 950 Cases Coordinated By the AGMT Study ...
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/9/2019
• RORA Is a Potential Prognostic Biomarker and Therapeutic Target for Patients with Acute Myeloid Leukemia
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• CUL1: Novel Therapeutic Target in Myeloid Neoplasms Harboring -7/Del(7q)
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Integrated Analysis of Copy-Number Alterations and Gene Mutations in 2,000 Patients with Myeloid Neoplasms
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Can Monosomy 7 be Targeted By Next Generation Cereblon-Modulating Agents?
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• FA Gene Carrier Status Predisposes to Myeloid Neoplasms and Bone Marrow Failure in AdultsClinically Relevant Abstract
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Single Arm, Phase II Study of Eltrombopag to Enhance Platelet Count Recovery in Older Patients with Acute Myeloid Leukemia (AML) Undergoing Remission Induction Therapy
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Combined Treatment with Lenalidomide and Epoetin Alfa Leads to Durable Responses in Patients with Epo-Refractory, Lower Risk Non-Deletion 5q [Del(5q)] MDS: Final Resul...
  Jaroslaw P. Maciejewski, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all